[1] Almeda-Valdes P, Altamirano-Barrera A, Uribe M, et al. Metabolic Features of Alcoholic Liver Disease. Rev Recent Clin Trials, 2016, 11:220-226.
[2] Hsiang JC, Gane EJ, Bai WW, et al. Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol, 2015, 30:591-599.
[3] Li Q, Li WW, Yang X, et al. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B. Int J Cancer, 2012, 131:1197-1202.
[4] Kim G, Jang SY, Han E, et al. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study. Int J Cancer, 2017, 140:798-806.
[5] 中国医院协会. 《中国肝病诊疗管理规范》白皮书(节选). 临床肝胆病杂志,2014,30:197-209.
[6] American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2006, 29 Suppl 1: S43-S48.
[7] Chinese Diabetes Society. China guideline for type 2 diabetes. Chin J Diabetes, 2012, 20: s1-s36.
[8] Petersen MC, Vatner DF, Shulman GI. Regulation of hepatic glucose metabolism in health and disease. Nat Rev Endocrinol, 2017, 13:572-587.
[9] Tolman KG, Fonseca V, Dalpiaz A, et al. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care, 2007, 30:734-743.
[10] Li-Ng M, Tropp S, Danoff A, et al. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Dig Liver Dis, 2007, 39:549-556.
[11] Huang ZS, Huang TS, Wu TH, et al. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten‐year observation. J Gastroenterol Hepatol, 2010, 25:1420-1425.
[12] Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010, 362:1090-1101.
[13] Doi Y, Kubo M, Yonemoto K, et al. Liver enzymes as a predictor for incident diabetes in a Japanese population: the Hisayama study. Obesity(Silver Spring), 2007, 15:1841-1850.
[14] Simmons RK, Griffin SJ, Witte DR, et al. Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults. Diabetologia, 2017, 60: 2183-2191. |
